The terminal half-life of methylene blue after intravenous administration is approximately 5.25 hours, but its effects can persist, necessitating ongoing observation
Many studies on this one: Promote tendon and ligament healing by tendon outgrowth, cell survival, and cell migration in a rodent model of Achilles tendon rupture, and also when administered in drinking water to rats with damaged medial collateral ligaments Tendon-to-bone healing effective enough that they may actually successfully exchange the present reconstructive surgical methods Counter the damaging effects of NSAIDs like ibuprofen or advil on the gut lining so effectively that scientists termed BPC-157 a NSAIDs antidote one of which they say that no other single agent has portrayed a similar array of effects Repair the damage from inflammatory bowel disease (IBD) within just days of oral administration in a rodent model of IBD Help cure perdidontitis when administered in a rodent model of periodontitis, significantly enough to have scientists conclude that BPC 157 may represent a new peptide candidate in the treatment of periodontal disease Reverse systemic corticosteroid-impaired muscle healing, in rodent models where BPC-157 was administered orally once daily for 14 days to rats with crushed gastrocnemius muscle
When paired with semaglutide (as CagriSema), results climbed above 20%
Proteostasis: maintenance of protein homeostasis in cells, involving processes that regulate protein synthesis, folding, degradation, and clearance to ensure proper protein function and prevent cellular dysfunction and disease
